<code id='822D044796'></code><style id='822D044796'></style>
    • <acronym id='822D044796'></acronym>
      <center id='822D044796'><center id='822D044796'><tfoot id='822D044796'></tfoot></center><abbr id='822D044796'><dir id='822D044796'><tfoot id='822D044796'></tfoot><noframes id='822D044796'>

    • <optgroup id='822D044796'><strike id='822D044796'><sup id='822D044796'></sup></strike><code id='822D044796'></code></optgroup>
        1. <b id='822D044796'><label id='822D044796'><select id='822D044796'><dt id='822D044796'><span id='822D044796'></span></dt></select></label></b><u id='822D044796'></u>
          <i id='822D044796'><strike id='822D044796'><tt id='822D044796'><pre id='822D044796'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:16474
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          How the messy conversation about Dolly changed bioethics
          How the messy conversation about Dolly changed bioethics

          SophieGogginsoftheNationalMuseumsScotlandinEdinburghviewsDollytheSheepduringtheopeningofamajornewdev

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Using force crossed my mind when examining a defiant young patient

          Inthis1895photo,nursesanddoctorsinoculateachildwithdiphtheriaantitoxinatthePasteurInstituteinNewYork